Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Beta-blockers
100%
Differential Effects
100%
Albuminuria
100%
Type 2 Diabetic Patients
100%
Microalbuminuria
100%
Carvedilol
85%
Metoprolol
57%
Blood Pressure
28%
Renin-angiotensin System Blockade
28%
Type 1 Diabetes Mellitus (T1DM)
14%
Antagonism
14%
Creatinine
14%
Confidence Interval
14%
Cardiovascular Risk Markers
14%
Angiotensin-converting Enzyme Inhibitor (ACEi)
14%
Type 2 Diabetes Mellitus (T2DM)
14%
Hypertension
14%
Antihypertensive Drugs
14%
Blood Pressure Lowering
14%
Hypertensive
14%
Metabolic Syndrome
14%
Washout Period
14%
Angiotensin Receptor Blockers
14%
Antioxidant Properties
14%
Current Analysis
14%
Blood Pressure Goals
14%
Spot Urine
14%
Urinary Albumin
14%
Blood Pressure Target
14%
Renin-angiotensin System Blockers
14%
Gemini
14%
Normoalbuminuria
14%
Glycemic Efficacy
14%
Nursing and Health Professions
Albuminuria
100%
Patient with Type 2 Diabetes
100%
Microalbuminuria
100%
Carvedilol
85%
Blood Pressure
71%
Angiotensin
42%
Renin
42%
Metoprolol
42%
Antioxidant
14%
Confidence Interval
14%
Diabetes Mellitus
14%
Dipeptidyl Carboxypeptidase Inhibitor
14%
Creatinine
14%
Cardiovascular Risk
14%
Metabolic Syndrome X
14%
Angiotensin Receptor Antagonist
14%
Antihypertensive Agent
14%
Metoprolol Tartrate
14%
Maturity Onset Diabetes of the Young
14%
Albumin
14%
Veterinary Science and Veterinary Medicine
Microalbuminuria
100%
Albuminuria
100%
Maturity Onset Diabetes of the Young
100%
Carvedilol
85%
Blood Pressure
71%
Metoprolol
57%
Renin-Angiotensin System
42%
Angiotensin
14%
Creatinine
14%
ACE Inhibitor
14%
Antihypertensive Agent
14%
Neuroscience
Carvedilol
100%
Metoprolol
66%
Angiotensin
50%
Renin
50%
Antioxidant
16%
Diabetes Mellitus
16%
Creatinine
16%
Angiotensin Receptor
16%
ACE Inhibitor
16%
Antihypertensive Agent
16%
Albumin
16%